Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial-Reference-Cited by-同舟云学术

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

Published:2022-06 Issue:6 Volume:21 Page:511-519
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Kvistad Christopher Elnan,Næss Halvor,Helleberg Bernt H,Idicula Titto,Hagberg Guri,Nordby Linn Marie,Jenssen Kristian N,Tobro Håkon,Rörholt Dag M,Kaur Kamaljit,Eltoft Agnethe,Evensen Kristin,Haasz Judit,Singaravel Guruparan,Fromm Annette,Thomassen Lars

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference22 articles.

1. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials;Lees;Lancet,2010

2. Do Clinicians Overestimate the Severity of Intracerebral Hemorrhage?

3. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke;Berge;Eur Stroke J,2021

4. Tenecteplase thrombolysis for acute ischemic stroke;Warach;Stroke,2020

5. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial;Van de Werf;Am Heart J,1999

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving thrombolysis efficiency for acute ischaemic stroke;The Lancet Neurology;2024-09

2. Optimizing Acute Ischemic Stroke Outcomes: The Role of Tenecteplase Before Mechanical Thrombectomy;Clinical Therapeutics;2024-09

3. Angioedema Following Tenecteplase for Acute Ischemic Stroke;Stroke;2024-08

4. In reply;Annals of Emergency Medicine;2024-08

5. Neues zur Thrombolyse zur Akuttherapie des ischämischen Schlaganfalls;InFo Neurologie + Psychiatrie;2024-08